DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20200690

Usefulness of serum albumin as a prognostic factor in dengue

Murali B. H., Shilpa Deborah Lysander, Meghana Nannapaneni

Abstract


Background: Dengue is a major public health problem throughout subtropical and tropical regions. In more severe or complicated dengue, patients present with a severe febrile illness characterized by abnormalities of hemostasis and increased vascular permeability, which in some instances results in a hypovolemic shock. Dengue is endemic in more than 100 countries in tropical and subtropical regions with an estimated 390 million infections occurring worldwide, among which 96 million infections are clinically apparent. The objective of this study is to assess the usefulness of serum albumin as a prognostic factor in dengue.

Method: This observational study enrolled 100 patients who were admitted in KIMS Hospital from June 2017 to June 2018 without any co morbidities as mentioned in the exclusion criteria. On day 4 of illness hemoglobin, packed cell volume, platelet and serum albumin were done, and the participants were classified into 3 groups based on clinical manifestation

Results: In this study, hemoglobin was elevated on day 4 in group 3 when compared to other groups and it was statistically significant. Hemoconcentration and low platelet values were also seen in group 3 when compared to other groups showing statistical significance.

Serum albumin was also low in group 3 when compared to other groups, which was strongly significant.

Conclusion: Hence serum albumin can be used as a prognostic factor in dengue.


Keywords


Background: Dengue is a major public health problem throughout subtropical and tropical regions. In more severe or complicated dengue, patients present with a severe febrile illness characterized by abnormalities of hemostasis and increased vascular perme

Full Text:

PDF

References


Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013 Apr 25;496(7446):504-7.

Mizumoto K, Ejima K, Yamamoto T, Nishiura H. On the risk of severe dengue during secondary infection: a systematic review coupled with mathematical modeling. J Vector Borne Dis. 2014 Sep;51(3):153-64.

Thomas EA, John M, Bhatia A. Cutaneous manifestations of dengue viral infection in Punjab (north India). Int J Dermatol. 2007 Jul;46(7):715-9.

Martina BEE, Koraka P, Osterhaus ADME. Dengue virus pathogenesis: An integrated view. Clin Microbiol Rev. 2009;22(4):564-81.

Rajapakse S, Rodrigo C, Rajapakse. Treatment of dengue fever. Infect Drug Resist. 2012;5:103.

Sigera PC, Amarasekara R, Rodrigo C, Rajapakse S, Weeratunga P, De Silva NL, et al. Risk prediction for severe disease and better diagnostic accuracy in early dengue infection; the Colombo dengue study. BMC Infect Dis. 2019 Aug 1;19(1):680.

La Russa VF, Innis BL. 11 Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol. 1995 Mar;8(1):249-70.

Reddy DY, M DR. Study on Serum Albumin as Prognostic Marker in Dengue. IOSR J Dent Med Sci. 2014;13(3):99-102.

Shankar P, B. P. Biochemical parameters (lactate dehydrogenase, serum albumin) as early predictor of severe dengue. Int J Contemp Pediatr. 2017;4(2):464.

Brito CAA, Albuquerque M de FMP, Lucena-Silva N. [Plasma leakage detection in severe dengue: when serum albumin quantification plays a role? Rev Soc Bras Med Trop. 40(2):220-3.